PT1107787E - Composicoes de vacinas contra a salmonella typhi - Google Patents

Composicoes de vacinas contra a salmonella typhi

Info

Publication number
PT1107787E
PT1107787E PT99944497T PT99944497T PT1107787E PT 1107787 E PT1107787 E PT 1107787E PT 99944497 T PT99944497 T PT 99944497T PT 99944497 T PT99944497 T PT 99944497T PT 1107787 E PT1107787 E PT 1107787E
Authority
PT
Portugal
Prior art keywords
compounds
vaccines against
salmonella typhi
against salmonella
typhi
Prior art date
Application number
PT99944497T
Other languages
English (en)
Inventor
Erik D Hondt
Pascale Demil
Christian Van Hoecke
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314288&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1107787(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9818910.3A external-priority patent/GB9818910D0/en
Priority claimed from GBGB9909080.5A external-priority patent/GB9909080D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of PT1107787E publication Critical patent/PT1107787E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0275Salmonella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255Salmonella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT99944497T 1998-08-28 1999-08-24 Composicoes de vacinas contra a salmonella typhi PT1107787E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818910.3A GB9818910D0 (en) 1998-08-28 1998-08-28 Novel formulation
GBGB9909080.5A GB9909080D0 (en) 1999-04-20 1999-04-20 Novel formulations

Publications (1)

Publication Number Publication Date
PT1107787E true PT1107787E (pt) 2003-07-31

Family

ID=26314288

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99944497T PT1107787E (pt) 1998-08-28 1999-08-24 Composicoes de vacinas contra a salmonella typhi

Country Status (11)

Country Link
EP (2) EP1107787B1 (pt)
JP (1) JP2002525277A (pt)
AR (1) AR023643A1 (pt)
AT (1) ATE240118T1 (pt)
AU (1) AU5739999A (pt)
CA (1) CA2341703A1 (pt)
DE (1) DE69907921T2 (pt)
DK (1) DK1107787T3 (pt)
ES (1) ES2193742T3 (pt)
PT (1) PT1107787E (pt)
WO (1) WO2000012129A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2828406B1 (fr) * 2001-08-08 2005-06-24 Aventis Pasteur Composition vaccinale bivalente havi
NZ575273A (en) 2006-09-07 2012-02-24 Glaxosmithkline Biolog Sa Method for making combination vaccine comprising inactivated poliovirus type 1, diptheria toxoid and tetanus toxoid
KR20150054800A (ko) 2012-09-10 2015-05-20 글리코박신 아게 변형된 항원을 포함하는 생체접합체 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
RU2111012C1 (ru) * 1997-04-15 1998-05-20 Вячеслав Леонидович Львов Вакцинный препарат для профилактики брюшного тифа

Also Published As

Publication number Publication date
ATE240118T1 (de) 2003-05-15
WO2000012129A2 (en) 2000-03-09
WO2000012129A3 (en) 2000-06-29
DE69907921T2 (de) 2004-03-11
JP2002525277A (ja) 2002-08-13
DK1107787T3 (da) 2003-09-01
EP1107787A2 (en) 2001-06-20
AR023643A1 (es) 2002-09-04
ES2193742T3 (es) 2003-11-01
EP1285666A1 (en) 2003-02-26
CA2341703A1 (en) 2000-03-09
AU5739999A (en) 2000-03-21
EP1107787B1 (en) 2003-05-14
DE69907921D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
BR9609258A (pt) Vacinas contra hepatite c
BR9607458A (pt) Vacina contra hepatite b
DK1124961T3 (da) Trombopoietiske forbindelser
FR2759577B1 (fr) Implant de sclerectomie profonde
NO20024042L (no) Aryl-fusjonerte azapolysykliske forbindelser
NO20006191D0 (no) Vaksine
NO20003303D0 (no) Vaksine
DK1267899T3 (da) ssa-inaktiverede salmonellavacciner
GB2385648B (en) Protection of underwater elongate members
PL343602A1 (en) Adjuvant-containing vaccines
DK1109574T3 (da) Vaccine mod seksuelt overförte sygdomme
GB2362444B (en) Protection of underwater elongate members
ID29886A (id) Pengepakan benda-benda fleksibel
HUP0005010A2 (en) Salmonella vaccine
MX9100654A (es) Vacuna contra haemophilus paragallinarum
PT1107787E (pt) Composicoes de vacinas contra a salmonella typhi
NO20004016L (no) Kosmetisk preparat inneholdende en forbindelse med aktivitetsstimulerende interlevkin-6
IS5694A (is) Bóluefni
DE69832127D1 (de) Wässrige Siliconzusammensetzung
ID29857A (id) Vaksin oral terhadap diare
DE19581751T1 (de) Urne
GB2386662B (en) Protection of underwater elongate members
GB0027644D0 (en) Fish vaccine
GB0021355D0 (en) Control of molluscs
GB0030765D0 (en) Fish vaccine